VivoSim Labs, INC. Logo

VivoSim Labs, INC.

Offers 3D human tissue models for predictive toxicology testing to accelerate drug discovery.

VIVS | US

Overview

Corporate Details

ISIN(s):
US68620A2033
LEI:
Country:
United States of America
Address:
11555 SORRENTO VALLEY ROAD, 92121 SAN DIEGO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company specializing in the development and application of three-dimensional (3D) human tissues for drug discovery. A continuation of Organovo's 3D bioprinting legacy, the company provides testing of drug candidates using its proprietary New Approach Methodologies (NAM) and NAMkind™ 3D models. VivoSim focuses on delivering human-relevant toxicology insights, particularly for liver and intestinal tissues, offering a predictive alternative to traditional animal studies. The company's services aim to provide crucial safety data before the commencement of costly clinical trials, thereby accelerating the drug development process.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VivoSim Labs, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VivoSim Labs, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VivoSim Labs, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BIOMERICA INC Logo
Develops diagnostic tests for GI, inflammatory diseases, and diabetes for lab and at-home use.
United States of America BMRA
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BiomX Inc. Logo
Develops phage therapies to target harmful bacteria in chronic diseases like cystic fibrosis.
United States of America PHGE
BioNTech SE Logo
Pioneering mRNA immunotherapies and vaccines to combat cancer and infectious diseases.
United States of America BNTX
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
BioRestorative Therapies, Inc. Logo
A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.
United States of America BRTX
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
BIO-TECHNE Corp Logo
Develops reagents and instruments for life sciences research and clinical diagnostic markets.
United States of America TECH

Talk to a Data Expert

Have a question? We'll get back to you promptly.